title: Locomotor activity in mice during chronic treatment with caffeine and withdrawal.
abstract: Chronic ingestion of caffeine by mice caused a marked reduction in locomotor exploratory activity. At least 4 days of withdrawal were required to restore activity to normal levels. Stimulatory effects of injected caffeine were lower in chronically treated mice and the biphasic dose-response (stimulatory followed by depressant) curve for injected caffeine was left shifted. Seven days of withdrawal were required before the dose-response curve to caffeine was identical to that of control mice. The depressant effects of a potent xanthine phosphodiesterase inhibitor, 1,3-dipropyl-7-methylxanthine, were blunted in caffeine-treated mice. The depressant effects of A1- and A2-selective adenosine analogs were enhanced after chronic caffeine. There was little or no effect of chronic caffeine on the stimulatory effects of dopaminergic agents (amphetamine, caffeine), while both depressant and stimulatory effects of cholinergic agents (nicotine, oxotremorine, scopolamine) were reduced. The results indicate that chronic caffeine affects functions of adenosine and cholinergic receptors related to regulation of locomotor exploratory activity.
authors.affiliation: Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
authors.forename: O
authors.initials: O
authors.lastname: Nikodijević
authors.forename: K A
authors.initials: KA
authors.lastname: Jacobson
authors.forename: J W
authors.initials: JW
authors.lastname: Daly
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010277:Parasympathomimetics / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D014970:Xanthines / Q000494:pharmacology
chemical_list: D015259:Dopamine Agents; D010277:Parasympathomimetics; D014970:Xanthines; C059953:1,3-dipropyl-7-methylxanthine; D002110:Caffeine; D000241:Adenosine; D015056:1-Methyl-3-isobutylxanthine